- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07646743
The Effect of Sleep Hygiene Education on Sleep Quality and Quality of Life in Patients With Painful Diabetic Polyneuropathy
Ağrılı Diyabetik Polinöropatili Hastalara Verilen Uyku Hijyeni Eğitiminin Uyku Kalitesi Ve Yaşam Kalitesi Üzerine Etkisi
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Background: Sleep disturbances are common in diabetic polyneuropathy (DPN) and adversely affect physical and psychological well-being. This study aimed to evaluate the effects of sleep hygiene education on sleep quality, pain severity, and quality of life in patients with painful DPN.
Methods: This randomized controlled trial was conducted between January 2025 and January 2026 and enrolled 24 patients with electrophysiologically confirmed painful DPN, randomized equally into intervention (n = 12) and control (n = 12) groups. The intervention group received a standardized sleep hygiene education protocol over three months; the control group continued routine care. Participant blinding was not feasible given the nature of the intervention; statistical analyses were conducted with group codes masked. Outcomes were assessed at baseline (T0), month 1 (T1), and month 3 (T2) using the Pittsburgh Sleep Quality Index (PSQI), Brief Pain Inventory (BPI), and SF-12 Health Survey.
Financial Support: The present study was supported by the Research Fund of Trakya University. Project No: 2025/19
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Edirne
-
Merkez, Edirne, Turkije (Türkiye), 22030
- Trakya University Medical Research and Application Centre
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Patients diagnosed with type 2 diabetes
- Patients confirmed diagnosis of diabetic polyneuropathy
- Patients not having any other illness besides diabetic polyneuropathy
- Patients not receiving treatment for diabetic polyneuropathy
- Patients with Multiple Sclerosis who volunteer to participate in the study
Exclusion Criteria:
- Patients diagnosed with Type 1 diabetes
- Multiple Sclerosis patients who do not volunteer to participate in the study
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ondersteunende zorg
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Ander: control
In the first interview, participants were informed about the research process.
Patient information forms and scales (Pittsburgh Sleep Quality Index (PSQI), Brief Pain Inventory (BPI), and SF-12 Health Survey) that would be used in data collection were explained to the participants.
Participants were informed about how often and how these forms and scales would be applied.
No intervention was applied to the participants in the control group in the study.
|
Participants in the control group continued with their routine treatment and care; no additional educational intervention was provided during this period.
|
|
Experimenteel: sleep hygiene education
The participants were informed about the research process during the first meeting.
Participants were told that, Participants were told that, if they agreed to participate in the study, Over a three-month period at home, the intervention group followed a standardized sleep hygiene education protocol.
Participants were provided with an educational booklet, and face-to-face training was conducted by a nurse in a dedicated outpatient clinic room during the initial visit.
Weekly reminder messages were sent to encourage participants to keep following the protocol, and adherence was checked at the 1- and 3-month outpatient visits.
|
Participants were provided with an educational booklet, and face-to-face training was conducted by a nurse in a dedicated outpatient clinic room during the initial visit.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Quality of sleep score
Tijdsspanne: tree month
|
Change in the mean scores of the Pittsburgh Sleep Quality Index (PSQI)at the first interview, on the 30th day and on the 90th day
|
tree month
|
|
Quality of life score
Tijdsspanne: three month
|
Change in the mean scores of the SF-12 Health Survey at the first interview, on the 30th day and on the 90th day
|
three month
|
|
Pain inventory score
Tijdsspanne: three month
|
Change in the mean scores of the Brief Pain Inventory (BPI) at the first interview, on the 30th day and on the 90th day
|
three month
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Ayfer Gunes, PhD, RN., Trakya University
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
- Neurologische manifestaties
- Endocriene systeemziekten
- Ziekten van het zenuwstelsel
- Psychische aandoening
- Neuromusculaire aandoeningen
- Ziekten van het perifere zenuwstelsel
- Suikerziekte
- Diabetes complicaties
- Slaap-waakstoornissen
- Slaapstoornissen, intrinsiek
- Dyssomnieën
- Pathologische aandoeningen, tekenen en symptomen
- Gedrag
- Tekenen en symptomen
- Gezondheidsgedrag
- Pijn
- Slaapinitiatie en -onderhoudsstoornissen
- Diabetische neuropathieën
- Slaap Hygiëne
Andere studie-ID-nummers
- 2025/19
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
IPD delen Ondersteunend informatietype
- LEERPROTOCOOL
- SAP
- ICF
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .